Literature DB >> 21956610

Bilaterality in papillary thyroid carcinoma: does it influence prognosis?

Jason D Prescott, Sareh Parangi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 21956610      PMCID： PMC3880204          DOI： 10.1245/s10434-011-2098-0

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN： 1068-9265            Impact factor:   5.344


× No keyword cloud information.
  8 in total

1.  BRAF(V600E) mutation and outcome of patients with papillary thyroid carcinoma: a 15-year median follow-up study.

Authors:  Rossella Elisei; Clara Ugolini; David Viola; Cristiana Lupi; Agnese Biagini; Riccardo Giannini; Cristina Romei; Paolo Miccoli; Aldo Pinchera; Fulvio Basolo
Journal:  J Clin Endocrinol Metab       Date:  2008-08-05       Impact factor: 5.958

2.  Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer.

Authors:  David S Cooper; Gerard M Doherty; Bryan R Haugen; Bryan R Hauger; Richard T Kloos; Stephanie L Lee; Susan J Mandel; Ernest L Mazzaferri; Bryan McIver; Furio Pacini; Martin Schlumberger; Steven I Sherman; David L Steward; R Michael Tuttle
Journal:  Thyroid       Date:  2009-11       Impact factor: 6.568

3.  Analysis of the rising incidence of thyroid cancer using the Surveillance, Epidemiology and End Results national cancer data registry.

Authors:  John D Cramer; Pingfu Fu; Karem C Harth; Seunghee Margevicius; Scott M Wilhelm
Journal:  Surgery       Date:  2010-12       Impact factor: 3.982

4.  The prevalence and prognostic value of BRAF mutation in thyroid cancer.

Authors:  Electron Kebebew; Julie Weng; Juergen Bauer; Gustavo Ranvier; Orlo H Clark; Quan-Yang Duh; Daniel Shibru; Boris Bastian; Ann Griffin
Journal:  Ann Surg       Date:  2007-09       Impact factor: 12.969

5.  Recurrence after treatment of micropapillary thyroid cancer.

Authors:  Douglas S Ross; Danielle Litofsky; Kenneth B Ain; Thomas Bigos; James D Brierley; David S Cooper; Bryan R Haugen; Jacqueline Jonklaas; Paul W Ladenson; James Magner; Jacob Robbins; Monica C Skarulis; David L Steward; Harry R Maxon; Steven I Sherman
Journal:  Thyroid       Date:  2009-10       Impact factor: 6.568

6.  Clinical behavior and outcome of papillary thyroid cancers smaller than 1.5 cm in diameter: study of 299 cases.

Authors:  Gabriella Pellegriti; Claudia Scollo; Gabriella Lumera; Concetto Regalbuto; Riccardo Vigneri; Antonino Belfiore
Journal:  J Clin Endocrinol Metab       Date:  2004-08       Impact factor: 5.958

Review 7.  Prognostic utility of BRAF mutation in papillary thyroid cancer.

Authors:  Mingzhao Xing
Journal:  Mol Cell Endocrinol       Date:  2009-10-31       Impact factor: 4.102

Review 8.  Thyroid cancer: the case for total thyroidectomy.

Authors:  O H Clark; K Levin; Q H Zeng; F S Greenspan; A Siperstein
Journal:  Eur J Cancer Clin Oncol       Date:  1988-02
  8 in total
  2 in total

1.  Association between Tumor Size and Bilateral Involvement in Papillary Thyroid Carcinoma.

Authors:  Suna Erkilic; Fatih Celenk; Zehra Bozdag
Journal:  J Thyroid Res       Date:  2016-04-24

2.  Risk Factors for Central Lymph Node Metastases and Benefit of Prophylactic Central Lymph Node Dissection in Middle Eastern Patients With cN0 Papillary Thyroid Carcinoma.

Authors:  Sandeep Kumar Parvathareddy; Abdul K Siraj; Saeeda O Ahmed; Felisa DeVera; Saif S Al-Sobhi; Fouad Al-Dayel; Khawla S Al-Kuraya
Journal:  Front Oncol       Date:  2022-01-17       Impact factor: 6.244
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.